在肝肝细胞癌中,BUB1 作为预后不良的生物标志物

Lili Zhang1,2, Yuzheng Zhuge3, Jingbin Ni4

  • 1Department of Gastroenterology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, Jiangsu Province, China. magiclily@njmu.edu.cn.

BMC immunology
|March 12, 2025
PubMed
概括

由西米达1 (BUB1) 基因不受抑制的芽在肝细胞癌 (HCC) 中被上调,与生存率差相关,并影响瘤免疫微环境. BUB1显示出作为HCC患者预后生物标志物的潜力.